Six Flags Entertainment Rises

Six Flags Entertainment Rises

Shares of Six Flags Entertainment climbed more than 2% intraday after Stifel analysts were cited as saying the sell-off in the stock this year is overdone. While admitting the company could “modestly underperform” in Q2, analysts Steven Wieczynski and Brad Boyer reiterated their Buy rating on the stock with a $73 price target. The recent declines in the share price could be attributable to poor weather that muted the start […]

Read More ˃
Heartland Express Acquires Interstate Distributor Co.

Heartland Express Acquires Interstate Distributor Co.

Heartland Express has acquired 100% of the outstanding stock of Interstate Distributer Co. of Tacoma, Washington from Saltchuk Resources, Inc., the company said Thursday. The enterprise value of the transaction was approximately $113 million. The transaction was funded through $94 million of Heartland’s existing cash, plus assumption of approximately $23 million of Interstate Distributer’s debt, and acquisition of $4 million in cash on Interstate Distributer’s balance sheet. Heartland expects to […]

Read More ˃
L3 Wins Multi-Year Order

L3 Wins Multi-Year Order

L3 Technologies said pre-market Thursday it has received an initial $89.2 million firm-fixed-price contract award from the U.S. Army. L3 said it will supply M783 Point Detonating/Delay (PD/DLY) Mortar Fuzes and M734A1 Multi-Option Fuze for Mortars (MOFM). This is a multi-year contract with a base award and four option years, which, if fully exercised, has the potential to exceed $230 million. The M783 and M734A1 fuzes are the U.S. Army’s […]

Read More ˃
Novartis Gets European Approval for Kisqali

Novartis Gets European Approval for Kisqali

Novartis AG said Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of Kisqali in combination with an aromatase inhibitor to treat postmenopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer as initial endocrine-based therapy. The CHMP recommendation of combining Kisqali with any aromatase inhibitor means […]

Read More ˃
OSI Wins Order

OSI Wins Order

OSI Systems shares gained more than 1% shortly after the open of trading Wednesday after it said pre-market that its security division has been awarded a contract valued at $23 million from an unidentified European airport group to provide multiple units of its RTT 110 explosive detection systems. The RTT employs an approach to provide high-resolution 3-D imaging, and its design allows for the inspection of hold baggage and air […]

Read More ˃